<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[BioMarin Pharmaceutical Inc. | Company News & Executive Profiles - BMRN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for BioMarin Pharmaceutical Inc.]]></description>
	<s:counts start="0" returned="10" found="24" />
	<language>en-us</language>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-326957.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Our first question will come from the line of Brian Abrahams of Oppenheimer & Co. Brian Abrahams &#8211; Oppenheimer & Co. Hi, thanks very much for taking my question. Two pipeline questions for Hank. On GALNS, you talked a little bit about the Phase I/II...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Jul 2009 19:07:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/oppenheimer+%2526+co..html"><![CDATA[Oppenheimer & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152699-biomarin-pharmaceutical-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[BioMarin Pharmaceutical Inc. BMRN   Q2 2009 Earnings Call Transcript   July 30, 2009 5:00 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Jul 2009 08:07:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical Inc., Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-293979.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions You have a question from the line of Salveen Kochnover of Collins Stewart. Please proceed. Salveen Kochnover - Collins Stewart  Good afternoon, thanks for taking my question. Could you provide us with some color on the first quarter Kuvan new patient additions...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Apr 2009 21:29:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/referral.html"><![CDATA[Referral]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-270748.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Chris Raymond from Robert Baird & Company. You may proceed sir.  Chris Raymond - Robert Baird & Co. Thanks for taking the question. Guys, I&#8217;m a little surprised by, I guess, it seems perhaps it&#8217;s the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 18 Feb 2009 17:38:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sg%2526a.html"><![CDATA[SG&A]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/gaap.html"><![CDATA[GAAP]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[La Jolla Drug Failure Leaves Few Options]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F120301-la-jolla-drug-failure-leaves-few-options%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: In both comedy and licensing deals, timing is everything. Today, there was no hilarity attached to the announcement that a mere five weeks after signing a deal worth up to $289m with BioMarin Pharmaceutial BMRN, La Jolla Pharmaceutical's LJPC lead drug Riquent had failed in phase III...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Feb 2009 11:50:03 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/la+jolla+pharmaceutical+co..html"><![CDATA[La Jolla Pharmaceutical Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LJPC</category>
		<category domain="tickers">BMRN,LJPC</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Rolls the Dice on a New Lupus Drug]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F113883-biomarin-rolls-the-dice-on-a-new-lupus-drug%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits: BioMarin Pharmaceutical BMRN and La Jolla Pharmaceutical Company announced that they have entered into an agreement to develop and commercialize Riquent®, La Jolla&#8217;s investigational drug for lupus nephritis, in the United States, Europe and all other territories of the world, excluding the Asia Pacific region. Following a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 08 Jan 2009 08:02:37 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Baker Hughes Inc., NovaMed, Inc., Hewitt Associates Inc., BioMarin Pharmaceutical Inc. and VistaPrint Ltd]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_30/ai_n30953095]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Baker Hughes Inc. (NYSE: BHI), NovaMed, Inc. (Nasdaq: NOVA), Hewitt Associates...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/baker+hughes+inc..html"><![CDATA[Baker Hughes Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/hewitt+associates+inc..html"><![CDATA[Hewitt Associates Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/new+york+stock+exchange.html"><![CDATA[New York Stock Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/novamed+inc..html"><![CDATA[NovaMed Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vistaprint+ltd..html"><![CDATA[VistaPrint Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BHI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVA</category>
		<category domain="tickers">BHI,BMRN,NDAQ,NOVA</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical Inc. Q3 2008 Earnings Conference Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-244611.html]]></link>
		<description><![CDATA[ Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of Salveen Kochnover with Collins Stewart. Please proceed. Salveen Kochnover - Collins Stewart Llc Thanks for taking my questions. Could you let us know if there is any more EAP or open label extension patients that remain to be...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 28 Oct 2008 18:01:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/uptick.html"><![CDATA[Uptick]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/senior+vice+president.html"><![CDATA[Senior Vice President]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/uptick.html"><![CDATA[Uptick]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/senior+vice+president.html"><![CDATA[Senior Vice President]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
	<item>
		<title><![CDATA[Biotech Outlook: M&A Will Continue]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F93480-biotech-outlook-m-a-will-continue%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&A [mergers and acquisitions] activity as well as top Buy recommendations.  How has earnings season gone this quarter?  Any major surprises? by...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 02 Sep 2008 12:31:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/amag+pharmaceuticals+inc..html"><![CDATA[AMAG Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/trimeris+inc..html"><![CDATA[Trimeris Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMAG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TRMS</category>
		<category domain="tickers">AMAG,BMRN,BMY,CELG,DNA,IMCL,MNKD,TRMS</category>
	</item>
	<item>
		<title><![CDATA[BioMarin Pharmaceutical, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224565.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionThank you madam. [Operator Instructions]. And your first question comes from the line of Brian Abrahams [ph] with Oppenheimer. Please proceed. Unidentified Analyst Hi guys, Thanks for taking my questions Just a question on the Kuvan launch, you mentioned that... it sounds like a vast majority of the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 05 Aug 2008 21:13:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="tickers">BMRN</category>
	</item>
</channel>
</rss>
